BDNF and depressive symptom measurement: He et al. [83] and Zhang et al. [84] reported that inhibition of miR-142-5p and miR-155 could attenuates depressive symptomatology in CUMS mice and patients with depression, respectively, via modulation of neuroinflammation through BDNF targeting.